In fact, DPP-4 inhibitors, aimed at elongating effect of endogenous incretins, are available for the treatment of type 2 diabetes though the glycemic effect of these medications are comparatively modest [24]
Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial
#2: Adverse effects and long-term efficacy There have been quite a few studies measuring adherence among different groups and with different formulations, so the exact numbers vary
The use of GLP-1s has been found to reduce food cravings for high-fat foods, sugary foods and alcohol
However, some may find that their weight loss allows them to be more active and exercise daily, which is a known factor in preventing weight re-gain
Physician-led models give the prescribing pathway a clear clinical owner from initial assessment through dose adjustment